Chapter
Fundraising for MDMA-Assisted Psychotherapy
1:07:55 - 1:14:54 (06:59)
The Multidisciplinary Association for Psychedelic Studies (MAPS) has raised $10 million towards their campaign for MDMA-assisted psychotherapy becoming a legal medicine, with a further $10 million needed to reach the finish line. The initial funding has been committed by various donors including, Peter Rahaul founder of RX Bar, Blake Mycosky founder of TOMS, and Steven Alexandra Cohen of the Steven and Alexandra Cohen Foundation.
Clips
A physician reached out to Tim Ferriss to help process the trauma and ethical dilemmas he faced as an ICU doctor during the pandemic, highlighting the need for more effective therapies.
1:07:55 - 1:09:40 (01:45)
Summary
A physician reached out to Tim Ferriss to help process the trauma and ethical dilemmas he faced as an ICU doctor during the pandemic, highlighting the need for more effective therapies. The possible reclassification of compounds like psychedelics could provide new treatment options for conditions like PTSD and depression.
ChapterFundraising for MDMA-Assisted Psychotherapy
Episode#440: Rick Doblin — The Psychedelic Domino That Tips All Others
PodcastThe Tim Ferriss Show
The Multidisciplinary Association for Psychedelic Studies (MAPS) and the Psychedelic Science Funders Collaborative (PSFC) have partnered to raise a $10 million matching grant for MDMA-assisted psychotherapy.
1:09:41 - 1:12:06 (02:25)
Summary
The Multidisciplinary Association for Psychedelic Studies (MAPS) and the Psychedelic Science Funders Collaborative (PSFC) have partnered to raise a $10 million matching grant for MDMA-assisted psychotherapy. This campaign aims to help make MDMA a medicine and prove its effectiveness in treating PTSD and other mental health disorders.
ChapterFundraising for MDMA-Assisted Psychotherapy
Episode#440: Rick Doblin — The Psychedelic Domino That Tips All Others
PodcastThe Tim Ferriss Show
The MDMA-assisted therapy organization, MAPS, has raised $10mn of the $30mn needed for Phase 3 trials for their treatment of PTSD.
1:12:07 - 1:14:54 (02:47)
Summary
The MDMA-assisted therapy organization, MAPS, has raised $10mn of the $30mn needed for Phase 3 trials for their treatment of PTSD. With investors committing funds, including a $5mn pledge from the Steven and Alexandra Cohen Foundation, MAPS is using a challenge grant to incentivize additional donations and fundraising towards the remaining $20mn.